|
|
7/12/2004 9:38:27 AM ET
SWISS MEDICA PRODUCT PUBLICITY CAMPAIGN LAUNCHED WITH MAJOR TELEVISION NEWS COVERAGE
OF O24
FOR IMMEDIATE RELEASE
Stock Symbol: OTC BB: SWME
July 12, 2004
SWISS MEDICA PRODUCT PUBLICITY CAMPAIGN LAUNCHED WITH MAJOR TELEVISION NEWS COVERAGE
OF O24
Toronto, Canada – Grant Johnson, President and COO of Swiss Medica (OTBB: SWME), is pleased to
announce the successful product publicity launch for the Company’s flagship product, the O24 pain relief
formula. The first major television editorial coverage for O24 aired on July 8th in the Phoenix, Arizona
metropolitan statistical area. According to the recent U.S. Census, Phoenix is the 6th largest city in the United
States.
Editorial coverage for O24 aired on KPHO-TV, a CBS affiliate, which the Nielsen media ratings service recently
ranked number two for television news ratings in the Phoenix metropolitan area. Footage was filmed at Swiss
Medica’s debut at the National Association of Chain Drug Store (NACDS) marketplace, last month, in San Diego.
Both Grant Johnson and Larry Holmes, the O24 celebrity spokesperson, were interviewed for the television news
editorial, and the newly packaged O24 pain relief product was prominently featured and discussed by the
television reporter.
The editorial coverage came from Max World News, which gathers newsworthy stories of a national interest,
primarily for local television news stations. Each week, Max World News feeds health and fitness-oriented news
stories via satellite to network affiliates, including ABC, NBC, CBS and Fox in all 210-television markets as well as
national cable networks such as CNN, CNBC and MSNBC.
Immediately following the twice-aired health news spot, Swiss Medica logged more than 200 telephone inquiries
and 300 unique visitors to its O24 website. In the first 36 hours, more than 75 people ordered the new O24 pain
relief product.
Grant Johnson said, “Phoenix was the news editor’s entry market for the Max World News feature news story. We
anticipate the same editorial feature might air on dozens more television stations in the near future, perhaps in
nearly all U.S. cities. We are excited about this instant consumer demand for O24 and what it forecasts as the
mainstream media take notice of our flagship product.”
Swiss Medica has retained Tampa-based Blue Skye, Inc as the agency of record for the O24 product publicity.
Sky Wallen, president of Blue Skye, was previously with BBDO/Proximity (London, UK). Ms. Wallen arranged the
Max World News interview and feature, as well as the recent product publicity for O24, prior to the NACDS show.
Additional editorial coverage is being pursued for the O24 product.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
market share through focused distribution strategies in multiple sales channels. Swiss Medica’s mission is to be
a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
visit our websites at www.swissmedica.com and www.024zone.com.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
transactions being contemplated, risks related to international sales and potential foreign currency exchange
fluctuations, continued acceptance of Swiss Medica’s products, increased levels of competition, technological
changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s
periodic reports filed with the United States Securities and Exchange Commission and other regulatory
authorities.
Investor Relations Contact:
David Jones
Swiss Medica Inc.
1 866 485 4243
djones@swissmedica.com
|
|
